仿制药研发中应关注的问题

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:jindere
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Nowadays, generic drugs hold high leading position in the clinical drugs in our country.Recently,many new regulation policies was brought out, the description of genetic drug is now defined as "having the same quality and therapeutic effect with Brand-name drug".Where is the future of generic drug R&D development? In this presentation, the questions of What/How to do and common deficiencies will be discussed in detail from the scientific point of view.Some thinking of generic drug R&D strategies will be put forward and wish to be paid more attention.
其他文献
  The injectable long acting drug delivery systems offer a number of advantages, including reduced dosing frequency, better therapeutic control, fewer side ef
会议
  Embolic drug delivery system (EDDS) is used in interventional therapy to treat tumor, arterio-venous malformations (AVMs) and hemorrhages, especially in dea
会议
会议
  The most important aspect of a generic drug approval is perhaps the therapeutic equivalence (TE) between the generic drug and the referenced brand drug, as
会议
  The novel drug delivery systems have been attracted by more and more pharmaceutical companies because of their bright future, great potential, and increasin
会议
会议
and
  Pharmaceutical formation consists of bioactive main drug and excipients with specific functions.The property of tablet is determined by the chemical structu
会议